Non-Lethal Biochemical Weapons Global Market Report 2024

The non-lethal biochemical weapons market size has grown strongly in recent years. It will grow from $1.98 billion in 2023 to $2.17 billion in 2024 at a compound annual growth rate (CAGR) of 9.6%. The growth observed in the historical period can be credited to factors such as the influence of historical incidents, considerations of cost and availability, public perception and acceptance, geopolitical factors, ethical and moral concerns, and regulatory frameworks.

The non-lethal biochemical weapons market size is expected to see strong growth in the next few years. It will grow to $3.08 billion in 2028 at a compound annual growth rate (CAGR) of 9.1%. The anticipated growth in the forecast period can be ascribed to rising demand, ethical considerations, insights gleaned from past incidents, public perception, and cost-efficiency. Key trends in the forecast period encompass innovative research and development, heightened demand for civilian applications, environmental and health concerns, integration of AI and robotics, and market liberalization.

The anticipated increase in military expenditure is poised to drive the growth of the non-lethal biochemical weapons market. Military expenditure encompasses spending on various aspects of the military, including weapons, operations, maintenance, personnel, and specific military equipment. In December 2022, member states of the European Defense Agency recorded a significant rise in spending on defense equipment, reaching $53.4 billion (€52 billion), marking a 16% increase compared to 2020. Total European defense spending also reached a new high of $228.6 billion (€214 billion), up 6% from 2020. This upward trend in military expenditure is a key driver for the non-lethal biochemical weapons market.

The prospect of terrorist attacks is expected to be a driving force behind the growth of the non-lethal biochemical weapons market. Terrorist attacks, deliberate and violent acts intended to instill fear, often involve the use of force or threats against civilians or governments to advance political, ideological, or religious goals. Non-lethal biochemical weapons play a role in these attacks by causing incapacitation or panic rather than immediate fatalities, posing a threat to public safety and security. The Global Terrorism Index reported that terrorist attacks became deadlier in 2022, with an average of 1.7 deaths per attack compared to 1.3 deaths per attack in 2021. The potential for terrorist attacks is a significant factor propelling the non-lethal biochemical weapons market.

A notable trend in the non-lethal biochemical weapons market is the development of innovative weapons by major companies. For instance, Apasteron Pvt. Ltd, an India-based company in the non-lethal weapons sector, is working on non-lethal weapons for the Indian army to counter potential threats from Chinese soldiers. Weapons such as Vajra, Trishul, and sapper punch have been developed to enhance security by incapacitating and blocking enemy vehicles while also acting as protective gloves.

Major companies in the non-lethal biochemical weapons market are focusing on the innovation of patrol carbines, specifically semi-automatic launchers, designed for law enforcement. A semi-automatic launcher automatically chambers a new round and resets the firing mechanism, and PepperBall, a US-based non-lethal weapon company, launched the PepperBall Patrol Carbine (PPC) in January 2022. This versatile and portable semi-automatic launcher is effective up to 150 feet and is designed for daily patrol and tactical use. With features such as a micro-honed barrel, adjustable aluminum sights, a Picatinny rail for accessories, and a customizable Mlok AR-15 handguard, the PPC aims to meet the needs of federal, state, and local law enforcement agencies.

In May 2021, Byrna Technologies Inc., a US-based non-lethal defense technology company, acquired Kore Outdoor Inc., a Canada-based company manufacturing non-lethal weapons. This strategic acquisition allows Byrna Technologies to expand its portfolio in the non-lethal weapons business, supporting the production of its current range of launchers during the transition period.

Major companies operating in the non-lethal biochemical weapons market report are Lamperd Less Lethal Inc., BAE Systems Inc., QinetiqGroup Inc., General Dynamics Corporation, TASER International Inc., Raytheon Company, Chemring Group plc, Textron Systems Corp., ALS Less-Lethal Systems Inc., ASP Inc., Combined Systems Inc., Condor Non-Lethal Technologies, ISPRA by Ei Ltd., Rheinmentall AG, Safariland LLC, Zarc International Inc., Genasys Inc., Axon Enterprise Inc., Bruzer Less Lethal, PACEM Solutions International, Mace Security International Inc., Fabrique Nationale Herstal, Mission Less Lethal Technologies, NonLethal Technologies Inc., Herstal SA, LRAD Corporation, PepperBall Technologies Inc., AMTEC Less-Lethal Systems Inc., Byrna Technologies Inc., UTS United Tactical Systems LLC, Fiocchi Munizioni S.p.A., RUAG International Holding Ltd.

North America was the largest region in the non-lethal biochemical weapons market in 2023. The regions covered in the non-lethal biochemical weapons market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the non-lethal biochemical weapons market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The primary categories of non-lethal biochemical weapons include directed energy and direct contact. A directed energy weapon utilizes highly focused energy to harm its targets. Operation types encompass defensive, offensive, and genetic attacks. These weapons find application among diverse end users, including military forces and law enforcement agencies.

The non-lethal biochemical weapons market research report is one of a series of new reports that provides non-lethal biochemical weapons market statistics, including non-lethal biochemical weapons industry global market size, regional shares, competitors with a non-lethal biochemical weapons market share, detailed non-lethal biochemical weapons market segments, market trends and opportunities, and any further data you may need to thrive in the non-lethal biochemical weapons industry. This non-lethal biochemical weapons market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.